Your browser doesn't support javascript.
loading
Use of heated tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2 vaccination among Japanese healthcare workers.
Yamamoto, Shohei; Tanaka, Akihito; Ohmagari, Norio; Yamaguchi, Koushi; Ishitsuka, Kazue; Morisaki, Naho; Kojima, Masayo; Nishikimi, Akihiko; Tokuda, Haruhiko; Inoue, Manami; Tanaka, Shiori; Umezawa, Jun; Okubo, Ryo; Nishimura, Kunihiro; Konishi, Maki; Miyo, Kengo; Mizoue, Tetsuya.
Afiliação
  • Yamamoto S; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: syamamoto@hosp.ncgm.go.jp.
  • Tanaka A; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Yamaguchi K; Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan.
  • Ishitsuka K; Department of social science, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Morisaki N; Department of social science, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Kojima M; Department of Frailty Research, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
  • Nishikimi A; Biosafety Division, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
  • Tokuda H; Bioresource Division, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
  • Inoue M; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan; Division of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Tanaka S; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Umezawa J; Division of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
  • Okubo R; Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, Tokyo, Japan.
  • Nishimura K; Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Osaka, Japan.
  • Konishi M; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Miyo K; Center for Medical Informatics Intelligence, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mizoue T; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Prev Med ; 161: 107123, 2022 08.
Article em En | MEDLINE | ID: mdl-35787841
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Produtos do Tabaco / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Prev Med Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Produtos do Tabaco / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Prev Med Ano de publicação: 2022 Tipo de documento: Article